婴儿肠内 ADME 基因表达的年龄特异性

IF 4.5 2区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL
Molecular Pharmaceutics Pub Date : 2024-09-02 Epub Date: 2024-08-09 DOI:10.1021/acs.molpharmaceut.4c00302
Eva J Streekstra, Tom Scheer-Weijers, Michael Bscheider, Sabine Fuerst-Recktenwald, Adrian Roth, Sven C D van Ijzendoorn, Sanne Botden, Willem de Boode, Martijn W J Stommel, Rick Greupink, Frans G M Russel, Evita van de Steeg, Saskia N de Wildt
{"title":"婴儿肠内 ADME 基因表达的年龄特异性","authors":"Eva J Streekstra, Tom Scheer-Weijers, Michael Bscheider, Sabine Fuerst-Recktenwald, Adrian Roth, Sven C D van Ijzendoorn, Sanne Botden, Willem de Boode, Martijn W J Stommel, Rick Greupink, Frans G M Russel, Evita van de Steeg, Saskia N de Wildt","doi":"10.1021/acs.molpharmaceut.4c00302","DOIUrl":null,"url":null,"abstract":"<p><p>In childhood, developmental changes and environmental interactions highly affect orally dosed drug disposition across the age range. To optimize dosing regimens and ensure safe use of drugs in pediatric patients, understanding this age-dependent biology is necessary. In this proof-of-concept study, we aimed to culture age-specific enteroids from infant tissue which represent its original donor material, specifically for drug transport and metabolism. Enteroid lines from fresh infant tissues (<i>n</i> = 8, age range: 0.3-45 postnatal weeks) and adult tissues (<i>n</i> = 3) were established and expanded to 3D self-organizing enteroids. The gene expression of drug transporters P-gp (<i>ABCB1</i>), BCRP (<i>ABCG2</i>), MRP2 (<i>ABCC2</i>), and PEPT1 (<i>SLC15A1</i>) and drug metabolizing enzymes CYP3A4, CYP2C18, and UGT1A1 was determined with RT-qPCR in fresh tissue and its derivative differentiated enteroids. Expression levels of P-gp, BCRP, MRP2, and CYP3A4 were similar between tissues and enteroids. PEPT1 and CYP2C18 expression was lower in enteroids compared to that in the tissue. The expression of UGT1A1 in the tissue was lower than that in enteroids. The gene expression did not change with the enteroid passage number for all genes studied. Similar maturational patterns in tissues and enteroids were visually observed for P-gp, PEPT1, MRP2, CYP3A4, CYP2C18, and VIL1. In this explorative study, interpatient variability was high, likely due to the diverse patient characteristics of the sampled population (e.g., disease, age, and treatment). To summarize, maturational patterns of clinically relevant ADME genes in tissue were maintained in enteroids. These findings are an important step toward the potential use of pediatric enteroids in pediatric drug development, which in the future may lead to improved pediatric safety predictions during drug development. We reason that such an approach can contribute to a potential age-specific platform to study and predict drug exposure and intestinal safety in pediatrics.</p>","PeriodicalId":52,"journal":{"name":"Molecular Pharmaceutics","volume":null,"pages":null},"PeriodicalIF":4.5000,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11372835/pdf/","citationCount":"0","resultStr":"{\"title\":\"Age-Specific ADME Gene Expression in Infant Intestinal Enteroids.\",\"authors\":\"Eva J Streekstra, Tom Scheer-Weijers, Michael Bscheider, Sabine Fuerst-Recktenwald, Adrian Roth, Sven C D van Ijzendoorn, Sanne Botden, Willem de Boode, Martijn W J Stommel, Rick Greupink, Frans G M Russel, Evita van de Steeg, Saskia N de Wildt\",\"doi\":\"10.1021/acs.molpharmaceut.4c00302\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In childhood, developmental changes and environmental interactions highly affect orally dosed drug disposition across the age range. To optimize dosing regimens and ensure safe use of drugs in pediatric patients, understanding this age-dependent biology is necessary. In this proof-of-concept study, we aimed to culture age-specific enteroids from infant tissue which represent its original donor material, specifically for drug transport and metabolism. Enteroid lines from fresh infant tissues (<i>n</i> = 8, age range: 0.3-45 postnatal weeks) and adult tissues (<i>n</i> = 3) were established and expanded to 3D self-organizing enteroids. The gene expression of drug transporters P-gp (<i>ABCB1</i>), BCRP (<i>ABCG2</i>), MRP2 (<i>ABCC2</i>), and PEPT1 (<i>SLC15A1</i>) and drug metabolizing enzymes CYP3A4, CYP2C18, and UGT1A1 was determined with RT-qPCR in fresh tissue and its derivative differentiated enteroids. Expression levels of P-gp, BCRP, MRP2, and CYP3A4 were similar between tissues and enteroids. PEPT1 and CYP2C18 expression was lower in enteroids compared to that in the tissue. The expression of UGT1A1 in the tissue was lower than that in enteroids. The gene expression did not change with the enteroid passage number for all genes studied. Similar maturational patterns in tissues and enteroids were visually observed for P-gp, PEPT1, MRP2, CYP3A4, CYP2C18, and VIL1. In this explorative study, interpatient variability was high, likely due to the diverse patient characteristics of the sampled population (e.g., disease, age, and treatment). To summarize, maturational patterns of clinically relevant ADME genes in tissue were maintained in enteroids. These findings are an important step toward the potential use of pediatric enteroids in pediatric drug development, which in the future may lead to improved pediatric safety predictions during drug development. We reason that such an approach can contribute to a potential age-specific platform to study and predict drug exposure and intestinal safety in pediatrics.</p>\",\"PeriodicalId\":52,\"journal\":{\"name\":\"Molecular Pharmaceutics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2024-09-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11372835/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Pharmaceutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1021/acs.molpharmaceut.4c00302\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/8/9 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.molpharmaceut.4c00302","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

在儿童时期,发育变化和环境相互作用会对各年龄段口服药物的处置产生很大影响。为了优化给药方案,确保儿科患者安全用药,了解这种与年龄相关的生物学特性十分必要。在这项概念验证研究中,我们的目标是从婴儿组织中培养特定年龄的肠球菌,这些肠球菌代表了药物转运和代谢的原始供体材料。我们建立了来自新鲜婴儿组织(n = 8,年龄范围:出生后 0.3-45 周)和成人组织(n = 3)的肠球菌系,并将其扩增为三维自组织肠球菌。采用 RT-qPCR 方法测定了新鲜组织及其衍生物分化肠组织中药物转运体 P-gp (ABCB1)、BCRP (ABCG2)、MRP2 (ABCC2) 和 PEPT1 (SLC15A1) 以及药物代谢酶 CYP3A4、CYP2C18 和 UGT1A1 的基因表达。P-gp、BCRP、MRP2 和 CYP3A4 的表达水平在不同组织和肠组织中相似。与组织相比,PEPT1 和 CYP2C18 在肠组织中的表达较低。组织中 UGT1A1 的表达低于肠内。所研究的所有基因的表达量并不随肠球菌的通过数而变化。肉眼观察到 P-gp、PEPT1、MRP2、CYP3A4、CYP2C18 和 VIL1 在组织和肠道中的成熟模式相似。在这项探索性研究中,患者之间的差异很大,这可能是由于取样人群的患者特征各不相同(如疾病、年龄和治疗)。总之,组织中与临床相关的 ADME 基因的成熟模式在肠液中得以保持。这些发现是在儿科药物开发中潜在使用儿科肠道组织的重要一步,将来可能会改善药物开发过程中的儿科安全性预测。我们认为,这种方法有助于建立一个潜在的特定年龄平台,用于研究和预测儿科药物暴露和肠道安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Age-Specific ADME Gene Expression in Infant Intestinal Enteroids.

Age-Specific ADME Gene Expression in Infant Intestinal Enteroids.

In childhood, developmental changes and environmental interactions highly affect orally dosed drug disposition across the age range. To optimize dosing regimens and ensure safe use of drugs in pediatric patients, understanding this age-dependent biology is necessary. In this proof-of-concept study, we aimed to culture age-specific enteroids from infant tissue which represent its original donor material, specifically for drug transport and metabolism. Enteroid lines from fresh infant tissues (n = 8, age range: 0.3-45 postnatal weeks) and adult tissues (n = 3) were established and expanded to 3D self-organizing enteroids. The gene expression of drug transporters P-gp (ABCB1), BCRP (ABCG2), MRP2 (ABCC2), and PEPT1 (SLC15A1) and drug metabolizing enzymes CYP3A4, CYP2C18, and UGT1A1 was determined with RT-qPCR in fresh tissue and its derivative differentiated enteroids. Expression levels of P-gp, BCRP, MRP2, and CYP3A4 were similar between tissues and enteroids. PEPT1 and CYP2C18 expression was lower in enteroids compared to that in the tissue. The expression of UGT1A1 in the tissue was lower than that in enteroids. The gene expression did not change with the enteroid passage number for all genes studied. Similar maturational patterns in tissues and enteroids were visually observed for P-gp, PEPT1, MRP2, CYP3A4, CYP2C18, and VIL1. In this explorative study, interpatient variability was high, likely due to the diverse patient characteristics of the sampled population (e.g., disease, age, and treatment). To summarize, maturational patterns of clinically relevant ADME genes in tissue were maintained in enteroids. These findings are an important step toward the potential use of pediatric enteroids in pediatric drug development, which in the future may lead to improved pediatric safety predictions during drug development. We reason that such an approach can contribute to a potential age-specific platform to study and predict drug exposure and intestinal safety in pediatrics.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Molecular Pharmaceutics
Molecular Pharmaceutics 医学-药学
CiteScore
8.00
自引率
6.10%
发文量
391
审稿时长
2 months
期刊介绍: Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development. Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Mechanistic Drug Delivery and Drug Targeting research on modulating activity and efficacy of a drug or drug product is within the scope of Molecular Pharmaceutics. Theoretical and experimental peer-reviewed research articles, communications, reviews, and perspectives are welcomed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信